FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain. “PRIM Group in Spain serves as a perfect … Continue Reading
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico
FREDERICK, MD, March 30, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ (OTC: BIEL) today announced its distribution partner in Mexico has received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico.e Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico. It is expected … Continue Reading
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
February 28, 2022 07:00 ET | Source: BioElectronics Corporation FREDERICK, MD, Feb. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) is pleased to update, in a letter from its Chairman, Richard Staelin, Ph.D., new distribution partners, personnel changes, and new clinical research studies. SALES UPDATE: BioElectronics Corporation is pleased to announce that it has signed … Continue Reading
BioElectronics Corporation Announces Major Lenders Forgoing Interest for a 3rd Consecutive Year; New Research Projects Underway
Jan 3, 2022 6:01:09 AMOTC Markets Group Inc. News Service — FREDERICK, MD, Jan. 03, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to announce that the managers of the firm’s two largest lenders, Ibex LLC and St. John’s LLC, both of which are controlled by Whelan family members, have agreed to forgo … Continue Reading
Press Release: BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com
BioElectronics Corporation to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com Frederick, MD, Oct. 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC: BIEL), a leader in the development and manufacturing of non-invasive electroceuticals, today announced that Sree Koneru, Ph.D., will present at the Pain Management Investor Forum to be … Continue Reading
BioElectronics Corporation Discusses Q2 Financials
Revenue Growth Exceeds 665% FREDERICK, MARYLAND, Aug. 30, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) said today that it would like to clarify information about the Company and acknowledge the investor community’s request for comments following Q2 financials. Key facts from the Q2 financials many of which were found in the footnotes: The … Continue Reading
BioElectronics Corporation Reports Double Digit Quarterly Sales Growth, KT Health and DJO Launches Outpacing Forecasts
Looking ahead, the Company is now working with their three major channel partners, i.e., KT Health and Scott Specialties in the OTC space, and Medi-Launch in the prescription medical market, to solidify new orders after strong initial product launches that took place in Q1 2021.
BioElectronics Corporation Announces Substantial Increase in 4th Quarter 2020 Revenue; Major Convertible Debt Holders Agree to Forego Interest in 2021
BIEL +23.33% Frederick, Maryland, Jan. 19, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK:BIEL) is pleased to report that Q4 revenue for 2020 exceeded $519,000, representing an increase of 241% when compared to Q3 revenue in 2020 ($151,956). Correspondingly, Q4 2020 revenue represents an increase of 233% when compared to the cumulative revenue of … Continue Reading
BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx — Drug-Free Pain Therapy Devices
Opens the Sales Market for 33+ Additional Countries FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices. The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue … Continue Reading
BioElectronics Chairman Outlines New Direction for Company
FREDERICK, MD, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), (www.bielcorp.com) today released a Chairman’s Letter to Shareholders written by Dr. Richard Staelin, the Company’s Chairman of the Board. Dear BioElectronics Shareholders : The purpose of this letter is to update you on the activities of BioElectronics Corporation over the … Continue Reading
Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation
FREDERICK, MD, June 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com, the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms. Patricia Whelan. “The management team at BioElectronics thanks Patricia Whelan for her … Continue Reading
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug
FREDERICK, MD, Aug. 20, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has filed a 510(k), Premarket Notification application with the U.S. Food and Drug Administration (FDA). The application is to seek expanded market clearance for the drug free, over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical … Continue Reading
BioElectronics Corporation Reports Q3 Earnings
Nov. 16, 2021 7:00 AM ETBioElectronics Corporation (BIEL) Year over Year Revenue Growth Exceeds 463% FREDERICK, MARYLAND, Nov. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (BIEL) (https://www.bielcorp.com/ OTC: BIEL) announces a 463% increase in sales revenue resulting in a profitable 3rd quarter. Keeping in line with BIEL’s impressive year-over-year growth, the nine months ended September 30, … Continue Reading
BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market
BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market FREDERICK, MD, Dec. 15, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — BioElectronics Corporation (OTC PINK: BIEL), (www.bielcorp.com) is pleased to announce that it has executed an OEM agreement with KT Health, LLC to bring its innovative pain management devices to encompass retail and e-commerce … Continue Reading